Follow
Pablo Játiva Carbajal
Pablo Játiva Carbajal
Pharmacist - Master's Degree in Teaching - PhD in Health Sciences
Verified email at uclm.es
Title
Cited by
Cited by
Year
Nanoparticle crossing of blood–brain barrier: a road to new therapeutic approaches to central nervous system diseases
V Ceña, P Játiva
Nanomedicine 13 (13), 1513-1516, 2018
1992018
Second generation amphiphilic poly-lysine dendrons inhibit glioblastoma cell proliferation without toxicity for neurons or astrocytes
J Janiszewska, I Posadas, P Jativa, M Bugaj-Zarebska, ...
PloS one 11 (11), e0165704, 2016
352016
Use of nanoparticles for glioblastoma treatment: a new approach
P Játiva, V Ceña
Nanomedicine 12 (20), 2533-2554, 2017
292017
Molecular determinants for cyclo-oligosaccharide-based nanoparticle-mediated effective siRNA transfection
D Manzanares, I Araya-Durán, L Gallego-Yerga, P Játiva, ...
Nanomedicine 12 (13), 1607-1621, 2017
152017
A β-Cyclodextrin-based nanoparticle with very high transfection efficiency unveils siRNA-activated TLR3 responses in human prostate cancer cells
C de la Torre, P Játiva, I Posadas, D Manzanares, JLJ Blanco, CO Mellet, ...
Pharmaceutics 14 (11), 2424, 2022
42022
The styryl benzoic acid derivative DC10 potentiates radiotherapy by targeting the xCT-glutathione Axis
S Sarowar, D Cirillo, P Játiva, MH Nilsen, SMA Otragane, J Heggdal, ...
Frontiers in Oncology 12, 786739, 2022
22022
Styrylbenzoic acid derivative DC10 potentiates radiotherapy by inhibiting glutathione synthesis, leading to increased oxidative stress and cancer cell death
S Sarowar, D Cirillo, P Jativa, MH Nilsen, SMA Otragane, JI Heggdal, ...
Cancer Research 82 (12_Supplement), 214-214, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7